GlassScriptPhysician profile
Barry M Mossman
NPI 1053516294
$6,965.77
in general payments reported to CMS, 2019-2025
45 companies · $17.29 in 2025
The $17.29 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,345 · 2020: $2,125 · 2021: $368 · 2022: $728 · 2023: $1,091 · 2024: $291 · 2025: $17.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $805.99 | 2019-2023 | |
| Amgen INC. | $710.54 | 2019-2024 | Repatha, Evenity, Prolia |
| Novo Nordisk INC | $707.40 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $696.04 | 2019-2020 | |
| Lilly USA, LLC | $574.54 | 2019-2024 | Mounjaro, Trulicity, Jardiance |
| Glaxosmithkline, LLC. | $458.04 | 2019-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $419.80 | 2019-2023 | Farxiga |
| Pfizer INC. | $373.57 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $298.86 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $274.52 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.48 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $186.76 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.46 | 2019-2024 | Xifaxan |
| Amarin Pharma, INC. | $95.72 | 2019-2020 | |
| Abbott Laboratories | $93.93 | 2019-2024 | Freestyle Libre 3 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Mossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.